Damien Alan Perriman insider trades: Exozymes (EXOZ) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Damien reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | EXOZ | ↓ Sell | 3,729 | $5.21 | $19K | Direct | Oct 26, 2026 (14d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EXOZ insiders
Open-market trades in the last 12 months
About Damien Alan Perriman's insider trades
Damien Alan Perriman is Chief Commercial Officer at Exozymes (EXOZ). Since Oct 12, 2026, Damien has reported no open-market purchases and 1 sale worth $19K on SEC Form 4. In the last 12 months: 1 sale ($19K).
Their filings also include option exercises (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EXOZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.